Upregulation of xCT by KSHV-encoded microRNAs facilitates KSHV dissemination and persistence in an environment of oxidative stress.

PLoS Pathogens
Zhiqiang QinChris Parsons

Abstract

Upregulation of xCT, the inducible subunit of a membrane-bound amino acid transporter, replenishes intracellular glutathione stores to maintain cell viability in an environment of oxidative stress. xCT also serves as a fusion-entry receptor for the Kaposi's sarcoma-associated herpesvirus (KSHV), the causative agent of Kaposi's sarcoma (KS). Ongoing KSHV replication and infection of new cell targets is important for KS progression, but whether xCT regulation within the tumor microenvironment plays a role in KS pathogenesis has not been determined. Using gene transfer and whole virus infection experiments, we found that KSHV-encoded microRNAs (KSHV miRNAs) upregulate xCT expression by macrophages and endothelial cells, largely through miR-K12-11 suppression of BACH-1-a negative regulator of transcription recognizing antioxidant response elements within gene promoters. Correlative functional studies reveal that upregulation of xCT by KSHV miRNAs increases cell permissiveness for KSHV infection and protects infected cells from death induced by reactive nitrogen species (RNS). Interestingly, KSHV miRNAs simultaneously upregulate macrophage secretion of RNS, and biochemical inhibition of RNS secretion by macrophages significantly red...Continue Reading

References

Jul 1, 1994·Transactions of the Royal Society of Tropical Medicine and Hygiene·M E SteinW R Bezwoda
May 4, 1995·The New England Journal of Medicine·E CesarmanD M Knowles
Jun 25, 1996·Proceedings of the National Academy of Sciences of the United States of America·W ZhongD Ganem
Jun 1, 1997·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·F A ShepherdG Levy
Jul 8, 1998·Proceedings of the National Academy of Sciences of the United States of America·P S GillP A Jones
Apr 14, 1999·Proceedings of the National Academy of Sciences of the United States of America·N DupinC Boshoff
Nov 9, 2000·The New England Journal of Medicine·M LuppiG Torelli
Jun 27, 2002·Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases·G PliakasP Matsiota-Bernard
Aug 1, 2002·Oncogene·Saravanakumar Dhakshinamoorthy, Anil K Jaiswal
Sep 18, 2002·The Journal of Biological Chemistry·Hiromi SasakiShiro Bannai
Jan 25, 2003·Anti-cancer Drugs·Peter W GoutMay C Robertson
Jul 11, 2003·Hematology/oncology Clinics of North America·Jamie H Von Roenn
Feb 7, 2004·The Journal of Immunology : Official Journal of the American Association of Immunologists·Karim AsehnouneEdward Abraham
Mar 25, 2004·Nature Reviews. Immunology·J David Lambeth
May 29, 2004·Journal of Acquired Immune Deficiency Syndromes : JAIDS·Pawan PyakurelThomas Heiden
Nov 30, 2004·Cellular Signalling·Karim AsehnouneEdward Abraham
Feb 9, 2005·International Journal of Cancer. Journal International Du Cancer·Emmanuelle BoulangerAntoine Gessain
Mar 23, 2005·Nature Methods·Sébastien PfefferThomas Tuschl
Apr 1, 2005·Proceedings of the National Academy of Sciences of the United States of America·Xuezhong CaiBryan R Cullen
Dec 20, 2005·The Journal of Pathology·Thomas F Schulz
Jan 21, 2006·The Journal of Immunology : Official Journal of the American Association of Immunologists·Giovanna RappoccioloCharles R Rinaldo
Jun 24, 2006·The Journal of Clinical Investigation·Christopher H ParsonsDean H Kedes
Jul 25, 2006·Cancer Treatment Reviews·Tazio VanniGilberto Schwartsmann

❮ Previous
Next ❯

Citations

Sep 3, 2013·Antioxidants & Redox Signaling·Claudia N Paiva, Marcelo T Bozza
May 14, 2014·Current Opinion in Virology·Ying ZhuShou-Jiang Gao
Jul 19, 2014·The Journal of Clinical Investigation·Federico N SoriaMaría Domercq
May 11, 2011·The Journal of Biological Chemistry·Hans-Jörg WarnatzMarie-Laure Yaspo
Apr 17, 2012·International Journal of Cell Biology·Zhiqiang QinChris Parsons
Jun 1, 2011·Advances in Virology·Fengchun YeShou-Jiang Gao
Feb 13, 2016·Frontiers in Microbiology·Pravinkumar PurushothamanSubhash C Verma
Jun 8, 2013·Current Opinion in Virology·Ying ZhuRolf Renne
Mar 20, 2013·Molecular Aspects of Medicine·Dimitrios FotiadisManuel Palacín
May 28, 2011·Biochimica Et Biophysica Acta·Joseph M Ziegelbauer
May 9, 2012·Wiley Interdisciplinary Reviews. RNA·Pauline Chugh, Dirk P Dittmer
Apr 10, 2016·Reviews in Medical Virology·Diogo Piedade, José Miguel Azevedo-Pereira
Jul 25, 2013·Free Radical Biology & Medicine·Xinghua ChengRichard C M Siow
Jun 9, 2016·Viruses·Diogo Piedade, José Miguel Azevedo-Pereira
Sep 2, 2016·The Journal of Clinical Investigation·Dirk P Dittmer, Blossom Damania
Mar 6, 2017·Trends in Microbiology·Jie QinChun Lu
Nov 22, 2012·Viruses·Dhivya RamalingamJoseph M Ziegelbauer
May 24, 2013·Journal of Virology·Sharof M TugizovJoel M Palefsky
Aug 24, 2013·Journal of Virology·Sang-Hoon SinDirk P Dittmer
Aug 30, 2013·Journal of Virology·Mark ManzanoEva Gottwein
Jul 1, 2015·Circulation Research·Li JiangDan Meng
Nov 12, 2016·Archives of Virology·Soowon KangHyeyoung Min
Sep 30, 2020·Annual Review of Virology·Yonggang PeiErle S Robertson

❮ Previous
Next ❯

Methods Mentioned

BETA
transfection
protein assay
transfections
light microscopy
PCR
electrophoresis

Software Mentioned

Image
iQ5
Excel
Ensembl

Related Concepts

Related Feeds

Aminoglycosides (ASM)

Aminoglycoside is a medicinal and bacteriologic category of traditional Gram-negative antibacterial medications that inhibit protein synthesis and contain as a portion of the molecule an amino-modified glycoside. Discover the latest research on aminoglycoside here.

Aminoglycosides

Aminoglycoside is a medicinal and bacteriologic category of traditional Gram-negative antibacterial medications that inhibit protein synthesis and contain as a portion of the molecule an amino-modified glycoside. Discover the latest research on aminoglycoside here.